This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.
This report describes CDC guidance for health departments for using a preferred selection of antibiotics when an area has reached a certain threshold of ciprofloxacin-resistant, meningococcal cases.
This report describes the association between experiences of certain forms of violence and harassment and suicidal ideation among transgender women and explores the moderation of the association by perceived social support.
This report examines whether transgender women who report behaviors associated with HIV acquisition were more likely to have had discussions with their clinician about pre-exposure prophylaxis (PrEP) and used PrEP.
This report describes how bivalent COVID-19 vaccines were nearly 50% effective in preventing COVID-19-related thromboembolic events among adults aged 65 and older and those on dialysis.
This report describes data from two randomized, double-blind clinical trials that investigated COVID-19 rebound following treatment with or without nirmatrelvir/ritonavir.